Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial.
By F. Chollet, J. Tardy, J. Albucher, C. Thalamas, E. Bérard, C. Lamy, Y. Béjot, S. Deltour, A. Jaillard, P. Niclot and 6 more. Lancet Neurology, 2011
892 citations recorded by the source corpus.
Subfields: Epidemiology, Neurology, Rehabilitation
View Paper: https://www.semanticscholar.org/paper/73c2feb43de7e8fdb8045a91d0b140edb281c234
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Neurology
In Rehabilitation
Citations in the corpus
- What Is the Evidence for Physical Therapy Poststroke? A Systematic Review and Meta-Analysis (2014, neutral): “windows, such as transcranial Direct Current Stimulation [570,571], repetitive Transcranial Magnetic Stimulation [572], or neuropharmacological interventions [573], may be promising.”
- Brain on stress: How the social environment gets under the skin (2012, background): “However, there are other potential applications, such as the recently reported ability of fluoxetine to enhance recovery from stroke (114).”
- Brain-machine interfaces in neurorehabilitation of stroke. (2015, positive): “Besides application of antidepressants (e.g. fluoxetine) that showed to significantly improve clinical outcome when administered early after stroke (Chollet et al., 2011, 2014; Mead et al., 2013), techniques aiming at purposeful modulation of this circuit's activity, such as rt-fMRI or DBS…”
- Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications (2021, background): “prescription of fluoxetine in combination with physiotherapy improved motor recovery three months after the onset of the disease in stroke patients with moderate to severe motor dysfunction.(379) Moreover, a randomized controlled clinical study revealed that fluoxetine could significantly reduce the”